Vycor Medical (VYCO) Net Cash Flow (2010 - 2026)
Vycor Medical's (VYCO) quarterly Net Cash Flow came in at $86652.0 in Q1 2026, up 294.29% year-on-year from $21976.6 in Q1 2025, and up 280.85% on a QoQ basis from $22752.0 in Q4 2025.
Vycor Medical (VYCO) Net Cash Flow (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Net Cash Flow data on file, last reported at $86652.0 in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 294.29% year-over-year to $86652.0 in Q1 2026; TTM through Mar 2026 was $115362.0, a 571.02% increase from a year earlier, with the FY2025 full-year figure at -$18666.0, down 138.6% from the prior year.
- Net Cash Flow for Q1 2026 stood at $86652.0, up from $22752.0 in the prior quarter.
- Over the last five years, Net Cash Flow for VYCO reached as high as $86652.0 in Q1 2026 and fell as low as -$51985.0 in Q4 2024.
- Historically, Net Cash Flow has averaged $5215.6 across 5 years, with a median of $4465.0 in 2022.
- Across the five-year window, Net Cash Flow plunged 363.45% in 2023 and surged 1247.37% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at $4465.0 in 2022, then plunged by 363.45% to -$11763.0 in 2023, then tumbled by 341.94% to -$51985.0 in 2024, then jumped by 143.77% to $22752.0 in 2025, then surged by 280.85% to $86652.0 in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $86652.0 in Q1 2026, $22752.0 in Q4 2025, and -$35470.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 86,652.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,652.00 |
| Mar 31, 2026 | 86,652.00 |
| Dec 31, 2025 | 22,752.00 |
| Dec 31, 2025 | 22,752.00 |
| Sep 30, 2025 | -35,470.00 |
| Sep 30, 2025 | -35,470.00 |
| Jun 30, 2025 | 41,428.00 |
| Jun 30, 2025 | 41,428.00 |
| Mar 31, 2025 | -44,599.00 |
| Mar 31, 2025 | -44,599.00 |
| Dec 31, 2024 | -51,985.00 |
| Dec 31, 2024 | -51,985.00 |
| Sep 30, 2024 | 38,337.00 |
| Sep 30, 2024 | 38,337.00 |
| Jun 30, 2024 | 75,439.00 |
| Jun 30, 2024 | 75,439.00 |
| Mar 31, 2024 | -13,434.00 |
| Mar 31, 2024 | -13,434.00 |
| Dec 31, 2023 | -11,763.00 |
| Dec 31, 2023 | -11,763.00 |